Boston An independent LDT provider

Press releases

October 26, 2018 | REGULATORY

Immunovia AB (Publ) nomination committee appointed for AGM 2019

Read press release
October 8, 2018 | REGULATORY

Immunovia announces strategic focus centered on IMMray™ blood-based biomarker signatures for rheumatoid arthritis within autoimmunity

Read press release
October 4, 2018

Immunovia PanFAM-1 clinical trial now available on ClinicalTrials.gov, the largest clinical trials database in the world

Read press release
September 28, 2018

Invitation to conference call regarding Immunovia’s autoimmune diseases strategy on October 8, 2018

Read press release
September 28, 2018 | REGULATORY

Increase in share capital and number of shares in Immunovia

Read press release
August 24, 2018 | REGULATORY

Immunovia Interim report, January-June 2018

Read press release
August 23, 2018

Invitation to presentation of Immunovia´s interim report January-June 2018 and comments to the previously published autoimmunity study results

Read press release
August 22, 2018 | REGULATORY

Breakthrough in autoimmune testing – IMMrayTM based novel biomarker signature identifies patients with anti-CCP negative rheumatoid arthritis

Read press release
August 16, 2018 | REGULATORY

Retrospective study results for IMMray™ PanCan-d conclude Immunovia needs to do further optimizations to meet the expected performance

Read press release
August 15, 2018

Journal of Clinical Oncology publishes that IMMray™ PanCan-d serum biomarker test detects early pancreatic cancer with 96% accuracy

Read press release
August 9, 2018

Invitation to Immunovia’s telephone conference on Thursday, the 9th of August, 2018 at 15:00 (CET)

Read press release
August 9, 2018

Immunovia`s blood-based IMMray™ biomarker array provides highly accurate diagnosis of non-small cell lung cancer in a new collaborative study

Read press release
1 20 21 22 23 24 31